Evidence map›Paper›PMID 34956531›Full record

ArticleAmerican journal of translational research2021

Effect of CT-guided microwave ablation for non-small cell lung cancer combined with severe chronic obstructive pulmonary disease.

Zhenhua Rong, Yongqi Ji, Faliang Dai, Fangfang Zhang, Yan Jiao, Yixing Liu

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhenhua RongDepartment of Minimally Invasive Tumor Intervention, Caoxian People's Hospital Heze 274400, Shandong Province, China.
Yongqi JiDepartment of Minimally Invasive Tumor Intervention, Caoxian People's Hospital Heze 274400, Shandong Province, China.
Faliang DaiDepartment of Minimally Invasive Tumor Intervention, Caoxian People's Hospital Heze 274400, Shandong Province, China.
Fangfang ZhangDepartment of Minimally Invasive Tumor Intervention, Caoxian People's Hospital Heze 274400, Shandong Province, China.
Yan JiaoDepartment of Minimally Invasive Tumor Intervention, Caoxian People's Hospital Heze 274400, Shandong Province, China.
Yixing LiuDepartment of Minimally Invasive Tumor Intervention, Caoxian People's Hospital Heze 274400, Shandong Province, China.
Cixian People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the perioperative complications and safety of microwave ablation (MA) therapy for patient's non-small cell lung cancer (NSCLC) combined with severe chronic obstructive pulmonary disease (COPD).

methodsA total of 28 patients with NSCLC combined with severe COPD in our center were analyzed for complications during MA therapy and post-treatment outcomes.

resultsAll patients were successfully ablated by puncture, with a tumor efficiency of 85.7% and no death within 30 days. The tumor tissues showed hypodense changes, cavitation, and decreased CT values when the CT was reexamined 24 hours after surgery. A total of 24 patients showed different surgery-related complications, and were cured after targeted treatments. During the follow-up, the lung tumor disappeared, while the fibrous scars and foci as well as pulmonary cavity still remained. CT imaging examination showed there was no enhancement in the tissue after resection.

conclusionIn this study, we confirmed that the complications of NSCLC combined with severe COPD after MA were manageable, safe and effective.

Indexed as

clinical effectmicrowave ablationnon-small cell lung cancerperioperative adverse eventSevere chronic obstructive pulmonary disease

Identifiers

PMID34956531
PMCPMC8661236
OpenAlexW4206888918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.